Hepatic steatosis and fibrosis: Non-invasive assessment

作     者：Rustam N Karanjia Mary ME Crossey I Jane Cox Haddy KS Fye Ramou Njie Robert D Goldin Simon D Taylor-Robinson 

作者机构：Liver Unit Division of Digestive Health Department of Surgery and Cancer Imperial College London St Mary’s Campus London W2 1NY United Kingdom Institute of Hepatology London Foundation for Liver Research 111 Coldharbour Lane London SE5 9NT United Kingdom Faculty of Life Sciences and Medicine King’s College London London SE5 9NT United Kingdom MRC Gambia Atlantic Road Fajara The Gambia 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2016年第22卷第45期

页      面：9880-9897页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：MMEC is supported by a Fellowship from the Sir Halley Stewart Trust (Cambridge, United Kingdom) SDT-R, MMEC, HKSF and RN have been participant workers in the PROLIFICA project in West Africa funded by the European Union Framework 7 

主　　题：Hepatic steatosis Fibrosis Non-invasive assessment Blood biomarker Ultrasound 

摘      要：Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation and consequent fibrosis, although hepatic steatosis is increasingly being recognised as an important pathological feature of disease, rather than being simply an innocent bystander. However, the current gold standard method of quantifying and staging liver disease, histological analysis by liver biopsy, has several limitations and can have associated morbidity and even mortality. Therefore, there is a clear need for safe and noninvasive assessment modalities to determine hepatic steatosis, inflammation and fibrosis. This review covers key mechanisms and the importance of fibrosis and steatosis in the progression of liver disease. We address non-invasive imaging and blood biomarker assessments that can be used as an alternative to information gained on liver biopsy.